tiprankstipranks
Advertisement
Advertisement

BTAI Stock Latest News

BioXcel Therapeutics enrolls first patients in BXCL501 trial
The FlyBioXcel Therapeutics enrolls first patients in BXCL501 trial
5d ago
BTAI
BioXcel Therapeutics: Undervalued Franchise with IGALMI PDUFA Catalyst Supports Buy Rating Despite Reduced Target
PremiumRatings
BioXcel Therapeutics: Undervalued Franchise with IGALMI PDUFA Catalyst Supports Buy Rating Despite Reduced Target
11d ago
BTAI
BioXcel Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe Fly
BioXcel Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
11d ago
BTAI
FDA Accepts BioXcel sNDA for At-Home IGALMI Use
PremiumCompany Announcements
FDA Accepts BioXcel sNDA for At-Home IGALMI Use
12d ago
8K
BTAI
BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA
PremiumThe Fly
BioXcel Therapeutics announces FDA acceptance of Igalmi sNDA
12d ago
BTAI
Morning Movers: AstraZeneca jumps following tozorakimab trial results
PremiumThe FlyMorning Movers: AstraZeneca jumps following tozorakimab trial results
17d ago
AGX
AZN
BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)
Premium
The Fly
BioXcel Therapeutics reports Q4 EPS (58c), consensus (63c)
17d ago
BTAI
BioXcel Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
BioXcel Therapeutics initiated with a Buy at Rodman & Renshaw
27d ago
BTAI
BioXcel Therapeutics Announces Registered Direct Equity Financing
PremiumCompany Announcements
BioXcel Therapeutics Announces Registered Direct Equity Financing
1M ago
8K
BTAI
BioXcel price target lowered to $6 from $10 at H.C. Wainwright
PremiumThe Fly
BioXcel price target lowered to $6 from $10 at H.C. Wainwright
1M ago
BTAI
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
PremiumThe Fly
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
1M ago
BTAI
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
PremiumThe Fly
BioXcel Therapeutics announces results from Phase 2 trial of BXCL501
1M ago
BTAI
BTAI Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBTAI Upcoming Earnings Report: What to Expect?
1M ago
BTAI
BioXcel Therapeutics to host KOL roundtable on Alzheimer’s dementia
Premium
The Fly
BioXcel Therapeutics to host KOL roundtable on Alzheimer’s dementia
2M ago
BTAI
BioXcel Highlights IGALMI At-Home Acute Agitation Opportunity
Premium
Company Announcements
BioXcel Highlights IGALMI At-Home Acute Agitation Opportunity
2M ago
8K
BTAI
BioXcel completes updated market opportunity assessment for Igalmi
PremiumThe Fly
BioXcel completes updated market opportunity assessment for Igalmi
2M ago
BTAI
BioXcel sets milestone bonuses amid pivotal IGALMI review
PremiumCompany Announcements
BioXcel sets milestone bonuses amid pivotal IGALMI review
2M ago
8K
BTAI
One new option listing and option delistings on January 20th
PremiumThe Fly
One new option listing and option delistings on January 20th
3M ago
CVM
TEF
BioXcel seeks FDA approval for at-home IGALMI use
PremiumCompany Announcements
BioXcel seeks FDA approval for at-home IGALMI use
3M ago
8K
BTAI
BioXcel Therapeutics submits sNDA to U.S. FDA for Igalmi
PremiumThe FlyBioXcel Therapeutics submits sNDA to U.S. FDA for Igalmi
3M ago
BTAI
BioXcel Therapeutics names interim CCO amid IGALMI expansion
Premium
Company Announcements
BioXcel Therapeutics names interim CCO amid IGALMI expansion
3M ago
8K
BTAI
BioXcel Therapeutics appoints Pavao as acting CCO
Premium
The Fly
BioXcel Therapeutics appoints Pavao as acting CCO
3M ago
BTAI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >